Gliadel for Pituitary Adenomas and Craniopharyngiomas
- 1 August 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 53 (2) , 255-260
- https://doi.org/10.1227/01.neu.0000073783.96617.3a
Abstract
OBJECTIVE. We developed a protocol for a clinical trial of postresection implantation of Gliadel wafers in patients with aggressive, relentlessly recurKeywords
This publication has 9 references indexed in Scilit:
- New chemotherapy options for the treatment of malignant gliomasCurrent Opinion in Oncology, 1999
- The Role of Cytotoxic Chemotherapy in the Management of Aggressive and Malignant Pituitary TumorsJournal of Clinical Endocrinology & Metabolism, 1998
- Chemotherapy with Adriamycin® (doxorubicin) and CCNU® (lomustine) in four children with recurrent craniopharyngiomaPublished by Elsevier ,1998
- Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind StudyNeurosurgery, 1997
- The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trialJournal of Neuro-Oncology, 1995
- Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomasThe Lancet, 1995
- The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymersJournal of Neurosurgery, 1992
- Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomasJournal of Neurosurgery, 1991
- Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngiomaJournal of Neuro-Oncology, 1984